Skip to main content
OpenTrials
Completed

NCT Number: NCT02003807

Incidence and Predictive Factor of Irritable Bowel Syndrome After Acute Diverticulitis in Korea

The pathogenesis of irritable bowel syndrome (IBS) is considered immune reaction of gastrointestinal tract. Therefore there is growing evidence that IBS could occur after gastroenteritis. However, little is known about the incidence of IBS after acute diverticulitis. We thought that post diverticulitis status could induce IBS because diverticulitis was also bowel inflammatory disorder. This survey was designed to identify incidence of post-diverticulitis IBS and risk factor in Korea.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diverticulitis and Irritable Bowel Syndrome Colonic Diseases Colonic Diseases, Functional Digestive System Diseases Diverticular Diseases Diverticulitis Gastroenteritis Gastrointestinal Diseases Intestinal Diseases Irritable Bowel Syndrome

Age range

20 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine

Seoul, 120-752, South Korea

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 20 years or over
  • Patients who diagnosed diverticulitis by CT scan from 2006 to 2010 (Case)
  • Patients who admitted to hospital because of non-gastrointestinal disorder (Control)

Exclusion criteria

  • Patients who diagnosed IBS before diverticulitis (Case)
  • Patients who diagnosed IBS before admission (Control)
  • Patients with bowel resection surgery except for laparoscopic appendectomy
  • Pregnancy
  • Do not agree the consent of this study
  • Patients who dose not understand telephone survey such as foreigner, mental retardation.

Treatment and study plan

Primary outcomes

  1. The newly developed IBS

    Time frame: Survey was done from 15th July 2013 to 30th September 2013

    The primary outcome was newly developed IBS. This was checked by telephone survey from 15th July 2013 to 30th September 2013. IBS was diagnosed by Rome III criteria.

Sponsors and collaborators

Lead sponsor

Yonsei University

Other

Registry information

Important dates

Study start
2013
Primary completion
2013
Study completion
2013
First posted
Dec 6, 2013
Registry last updated
Dec 6, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.